Enzalutamide in metastatic prostate cancer before chemotherapy

T. M. Beer, A. J. Armstrong, D. E. Rathkopf, Y. Loriot, C. N. Sternberg, C. S. Higano, P. Iversen, S. Bhattacharya, J. Carles, S. Chowdhury, Ian D. Davis, J. S. de Bono, C. P. Evans, K. Fizazi, A. M. Joshua, C.-S. Kim, G. Kimura, P. Mainwaring, H. Mansbach, K. MillerS. B. Noonberg, F. Perabo, D. Phung, F. Saad, H. I. Scher, M.-E. Taplin, P. M. Venner, B. Tombal, S. Begbie, A. Bonaventura, A. Boyce, W. Chua, P. de Souza, et al

Research output: Contribution to journal › Article › peer-review

2139 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Enzalutamide in metastatic prostate cancer before chemotherapy'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science